CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
Desmetramadoldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04683926
NCT04683926Phase 1Completed
CompareCT.gov

A Phase 1 Randomized Single Oral Dose Cross-Over Study Investigating Desmetramadol Dose Proportionality And Food Effect In Normal Human Subjects

Syntrix Biosystems, Inc.·interventional·Posted Dec 24, 2020·Updated Apr 4, 2023

In Brief

A Phase 1 clinical trial evaluating Desmetramadol for Pain. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of the study is to investigate in healthy human subjects how much desmetramadol (Omnitram) gets in the blood after different oral doses are taken with or without food.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsCelerion, National Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
202120222023202420252026
First PostedDec 24, 2020
Enrollment StartJan 8, 2021
Primary CompletionJan 18, 2021
TodayJul 2, 2026
Enrollment to primary: 10 daysPosted 5.5 years ago

Interventions

Desmetramadoldrug

Analgesic